{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:44:37Z","timestamp":1793731477079,"version":"4.6.1"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.1001\/jamaoncol.2020.6332","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T18:34:35Z","timestamp":1608316475000},"page":"206","source":"Crossref","is-referenced-by-count":234,"title":["Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non\u2013Small Cell Lung Cancer"],"prefix":"10.1001","volume":"7","author":[{"given":"Katelyn M.","family":"Atkins","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California"},{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tafadzwa L.","family":"Chaunzwa","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayan","family":"Lamba","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle S.","family":"Bitterman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupendra","family":"Rawal","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Bredfeldt","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kozono","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth H.","family":"Baldini","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Nohria","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo J. W. L.","family":"Aerts","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Radiology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond H.","family":"Mak","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"coi200095r1","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3109\/0284186X.2010.504736","article-title":"Cardiac toxicity and radiation dose to the heart in definitive treated non\u2013small cell lung cancer.","volume":"49","author":"Schytte","year":"2010","journal-title":"Acta Oncol"},{"issue":"9","key":"coi200095r2","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/annonc\/mdq042","article-title":"Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non\u2013small-cell lung cancer.","volume":"21","author":"Hardy","year":"2010","journal-title":"Ann Oncol"},{"issue":"13","key":"coi200095r3","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1200\/JCO.2016.70.0229","article-title":"Cardiac toxicity after radiotherapy for stage III non\u2013small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy.","volume":"35","author":"Wang","year":"2017","journal-title":"J Clin Oncol"},{"issue":"13","key":"coi200095r4","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1200\/JCO.2016.71.6142","article-title":"Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non\u2013small-cell lung cancer.","volume":"35","author":"Dess","year":"2017","journal-title":"J Clin Oncol"},{"issue":"23","key":"coi200095r5","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1016\/j.jacc.2019.03.500","article-title":"Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer.","volume":"73","author":"Atkins","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"coi200095r6","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.jacc.2009.11.053","article-title":"Understanding radiation-induced vascular disease.","volume":"55","author":"Weintraub","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"coi200095r7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jacbts.2018.01.014","article-title":"Radiation-induced endothelial vascular injury: a review of possible mechanisms.","volume":"3","author":"Venkatesulu","year":"2018","journal-title":"JACC Basic Transl Sci"},{"issue":"2","key":"coi200095r8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","article-title":"Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non\u2013small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"issue":"2","key":"coi200095r9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jtho.2016.09.134","article-title":"Heart dose is an independent dosimetric predictor of overall survival in locally advanced non-small cell lung cancer.","volume":"12","author":"Speirs","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"7","key":"coi200095r10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1200\/JCO.19.01162","article-title":"Long-term results of NRG Oncology RTOG 0617: standard- versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non\u2013small-cell lung cancer.","volume":"38","author":"Bradley","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi200095r11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13014-019-1234-z","article-title":"Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study).","volume":"14","author":"Jacob","year":"2019","journal-title":"Radiat Oncol"},{"issue":"10066","key":"coi200095r12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments.","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"issue":"24","key":"coi200095r13","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC.","volume":"379","author":"Antonia","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"coi200095r14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/JTO.0b013e3182429682","article-title":"Defining local-regional control and its importance in locally advanced non\u2013small cell lung carcinoma.","volume":"7","author":"Machtay","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"2","key":"coi200095r15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.radonc.2017.10.001","article-title":"Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for stage III non\u2013small-cell lung cancer.","volume":"125","author":"Wang","year":"2017","journal-title":"Radiother Oncol"},{"issue":"1","key":"coi200095r16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijrobp.2017.05.022","article-title":"Incidence and predictors of pericardial effusion after chemoradiation therapy for locally advanced non\u2013small cell lung cancer.","volume":"99","author":"Ning","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"coi200095r17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.10.058","article-title":"Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer.","volume":"79","author":"Feng","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"coi200095r18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study.","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"issue":"9","key":"coi200095r19","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jacc.2017.12.048","article-title":"2017 Cardiovascular and stroke endpoint definitions for clinical trials.","volume":"71","author":"Hicks","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"coi200095r20","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1002\/sim.4509","article-title":"Classification accuracy and cut point?selection.","volume":"31","author":"Liu","year":"2012","journal-title":"Stat Med"},{"key":"coi200095r21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/01621459.1993.10476289","article-title":"On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data.","volume":"88","author":"Gaynor","year":"1993","journal-title":"J Am Statistic Assoc"},{"key":"coi200095r22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Statistic Assoc."},{"key":"coi200095r23","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Statistic Assoc."},{"key":"coi200095r24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/rssb.1972.34.issue-2","article-title":"Regression Models and Life-tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J Royal Statistic Soc Series B (Methodological)"},{"issue":"11","key":"coi200095r25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer.","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"coi200095r26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","article-title":"Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma.","volume":"34","author":"van Nimwegen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"6","key":"coi200095r27","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"1","key":"coi200095r28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mayocp.2015.09.009","article-title":"Prevalence of preexisting cardiovascular disease in patients with different types of cancer: the unmet need for onco-cardiology.","volume":"91","author":"Al-Kindi","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"coi200095r29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ijrobp.2018.12.044","article-title":"Is the importance of heart dose overstated in the treatment of non\u2013small cell lung cancer? a systematic review of the literature.","volume":"104","author":"Zhang","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"coi200095r30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2017.00001","article-title":"Results of a single institution experience with dose-escalated chemoradiation for locally advanced unresectable non\u2013small cell lung cancer.","volume":"7","author":"Bernard","year":"2017","journal-title":"Front Oncol"},{"issue":"1","key":"coi200095r31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1200\/JCO.2016.69.1378","article-title":"Impact of intensity-modulated radiation therapy technique for locally advanced non\u2013small-cell lung cancer: a secondary analysis of the NRG Oncology RTOG 0617 randomized clinical trial.","volume":"35","author":"Chun","year":"2017","journal-title":"J Clin Oncol"},{"issue":"9","key":"coi200095r32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/jnci\/djw034","article-title":"Institutional enrollment and survival among NSCLC patients receiving chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617.","volume":"108","author":"Eaton","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"coi200095r33","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/annonc\/mdx069","article-title":"Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA\/B non\u2013small-cell lung cancer: secondary analysis of a randomized trial.","volume":"28","author":"Guberina","year":"2017","journal-title":"Ann Oncol"},{"issue":"2","key":"coi200095r34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cllc.2016.06.004","article-title":"Matched-pair analysis of high dose versus standard dose definitive chemoradiation for locally advanced non\u2013small-cell lung cancer.","volume":"18","author":"Johnson","year":"2017","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"coi200095r35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13014-017-0772-5","article-title":"Is pulmonary artery a dose-limiting organ at risk in non\u2013small cell lung cancer patients treated with definitive radiotherapy?","volume":"12","author":"Ma","year":"2017","journal-title":"Radiat Oncol"},{"key":"coi200095r36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejca.2017.07.053","article-title":"Radiation dose to heart base linked with poorer survival in lung cancer patients.","volume":"85","author":"McWilliam","year":"2017","journal-title":"Eur J Cancer"},{"key":"coi200095r37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2020.06.031","article-title":"Novel methodology to investigate the impact of radiation dose to heart sub-structures on overall survival.","author":"McWilliam","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"coi200095r38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/COC.0000000000000135","article-title":"Dosimetric correlate of cardiac-specific survival among patients undergoing coronary artery stenting after thoracic radiotherapy for cancer.","volume":"40","author":"Sio","year":"2017","journal-title":"Am J Clin Oncol"},{"issue":"17","key":"coi200095r39","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1158\/1078-0432.CCR-19-2627","article-title":"Modeling the impact of cardiopulmonary irradiation on overall survival in NRG Oncology Trial RTOG 0617.","volume":"26","author":"Thor","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"3","key":"coi200095r40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.radonc.2016.04.025","article-title":"Impact of heart and lung dose on early survival in patients with non\u2013small cell lung cancer treated with chemoradiation.","volume":"119","author":"Tucker","year":"2016","journal-title":"Radiother Oncol"},{"issue":"1","key":"coi200095r41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijrobp.2017.04.026","article-title":"The impact of cardiac radiation dosimetry on survival after radiation therapy for non\u2013small cell lung cancer.","volume":"99","author":"Vivekanandan","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"coi200095r42","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.112.001183","article-title":"Ideal cardiovascular health is inversely associated with incident cancer: the Atherosclerosis Risk In Communities study.","volume":"127","author":"Rasmussen-Torvik","year":"2013","journal-title":"Circulation"},{"issue":"8","key":"coi200095r43","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jcmg.2018.04.028","article-title":"Radiation-associated cardiac disease: a practical approach to diagnosis and management.","volume":"11","author":"Desai","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3, suppl","key":"coi200095r44","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1016\/j.ijrobp.2009.06.091","article-title":"Radiation dose-volume effects in the lung.","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"coi200095r45","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ijrobp.2012.04.043","article-title":"Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis.","volume":"85","author":"Palma","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"coi200095r46","doi-asserted-by":"publisher","first-page":"S256","DOI":"10.1016\/j.ijrobp.2019.06.2537","article-title":"Dosimetric tradeoffs of mean heart dose reduction predicted by machine learning\u2013guided decision support software in lung cancer.","volume":"105","author":"Atkins","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2773837\/jamaoncology_atkins_2020_oi_200095_1613590884.03311.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T19:53:51Z","timestamp":1613850831000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2773837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2020.6332","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}